Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2018-08-21 | 2018-11-08 | 58634 |
| ACT OLOPATADINE 0.2% | 0.2% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65516 |
| ACT OLOPATADINE 0.1% | 0.1% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65519 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2018-12-04 | 2019-08-06 | 68608 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-02-05 | 2019-03-12 | 74792 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-06-03 | 2019-08-07 | 85468 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2019-06-13 | 2019-08-21 | 86601 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86905 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-18 | 2019-07-16 | 86908 |
| TEVA-LATANOPROST | 0.05MG | SOLUTION | Resolved | 2019-06-18 | 2019-08-06 | 86930 |
| CALMYLIN PSE WITH CODEINE | 30MG 3.3MG 100MG | SOLUTION | Resolved | 2019-06-27 | 2019-08-16 | 87659 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2019-06-27 | 2019-08-29 | 87665 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Actual shortage | 2019-06-27 | 2019-08-07 | 87673 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Actual shortage | 2019-06-27 | 2019-08-07 | 87676 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2019-06-27 | 2019-08-21 | 87684 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-07-02 | 2019-07-16 | 88167 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Resolved | 2019-08-06 | 2019-11-19 | 90935 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92180 |
| VINBLASTINE SULPHATE INJECTION | 1MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-10 | 92198 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92229 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |